calendar
29,475 catalysts · 10,013 approval · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
29,475 catalysts · 10,013 approval · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: SCIEGEN PHARMS. Form: CREAM. Route: TOPICAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: NALPROPION. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: HALEON US HOLDINGS. Form: CREAM. Route: TOPICAL
Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL
Sponsor: CEPHALON. Form: TABLET. Route: BUCCAL, SUBLINGUAL
Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: COSETTE. Form: SYRUP. Route: ORAL
Sponsor: PHARM ASSOC. Form: SYRUP. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SYRUP. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SYRUP. Route: ORAL
Sponsor: ANIMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: SOVEREIGN PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: GENUS. Form: SYRUP. Route: ORAL
Sponsor: LABS JUVISE. Form: CAPSULE. Route: ORAL
Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL
Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL
Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL
Sponsor: LABS JUVISE. Form: CAPSULE. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS
Sponsor: NALPROPION. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: TABLET, CHEWABLE. Route: ORAL